These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31707737)

  • 1. Vitamin K
    Cameli N; Zanniello R; Mariano M; Cristaudo A
    Contact Dermatitis; 2020 Mar; 82(3):189-190. PubMed ID: 31707737
    [No Abstract]   [Full Text] [Related]  

  • 2. "Crossed" allergic contact dermatitis caused by oxidized vitamin K
    Schneller-Pavelescu L; Ochando-Ibernón G; Vergara-de Caso E; Silvestre-Salvador JF
    Contact Dermatitis; 2019 Jan; 80(1):64-65. PubMed ID: 30264888
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical vitamin K1 may not be effective in preventing acneiform rash during cetuximab treatment in patients with metastatic colorectal cancer.
    Jo JC; Hong YS; Kim KP; Lee JL; Kim HJ; Lee MW; Lim SB; Yu CS; Kim JC; Kim JH; Kim TW
    Eur J Dermatol; 2013; 23(1):77-82. PubMed ID: 23238388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EVITA-a double-blind, vehicle-controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity.
    Hofheinz RD; Lorenzen S; Trojan J; Ocvirk J; Ettrich TJ; Al-Batran SE; Schulz H; Homann N; Feustel HP; Schatz M; Kripp M; Schulte N; Tetyusheva M; Heeger S; Vlassak S; Merx K
    Ann Oncol; 2018 Apr; 29(4):1010-1015. PubMed ID: 29360920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot clinical trial on the efficacy of prophylactic use of vitamin K1-based cream (Vigorskin) to prevent cetuximab-induced skin rash in patients with metastatic colorectal cancer.
    Pinta F; Ponzetti A; Spadi R; Fanchini L; Zanini M; Mecca C; Sonetto C; Ciuffreda L; Racca P
    Clin Colorectal Cancer; 2014 Mar; 13(1):62-7. PubMed ID: 24332355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial.
    Gaiser MR; Lorenzen S; Merx K; Trojan J; Ocvirk J; Ettrich TJ; Al-Batran SE; Schulz H; Homann N; Feustel HP; Schatz M; Kripp M; Schulte N; Heeger S; Vlassak S; Koch W; Hofheinz RD
    Ann Oncol; 2018 Dec; 29(12):2393-2395. PubMed ID: 30307464
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study.
    Rothschild SI; Betticher D; Zenhäusern R; Anchisi S; von Moos R; Pless M; Moosmann P; Popescu RA; Calderoni A; Dressler M; Rauch D; Pederiva S; Woelky R; Papet C; Bühler V; Borner M
    Cancer Chemother Pharmacol; 2019 Oct; 84(4):881-889. PubMed ID: 31444619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact dermatitis due to clarifying cream.
    Serra-Baldrich E; Dalmau J; Pla C; Muntañola AA
    Contact Dermatitis; 2005 Sep; 53(3):174-5. PubMed ID: 16128764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythema multiforme-like reaction resulting from vitamin K
    Pastor-Nieto MA; Gatica-Ortega ME; Melgar-Molero V; González-Muñoz P; Mollejo M; Schoendorff C; De Eusebio-Murillo E
    Contact Dermatitis; 2017 Nov; 77(5):343-345. PubMed ID: 29063687
    [No Abstract]   [Full Text] [Related]  

  • 10. Allergic contact dermatitis due to vitamin K1 contained in a cosmetic cream.
    Ruiz-Hornillos FJ; Prieto A; De Castro FJ; Martín E; De Barrio M; Tornero P; Sotés MR
    Contact Dermatitis; 2006 Oct; 55(4):246-7. PubMed ID: 16958924
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergic contact dermatitis caused by sodium chondroitin sulfate contained in a cosmetic cream.
    Vigan M
    Contact Dermatitis; 2014 Jun; 70(6):383-4. PubMed ID: 24846591
    [No Abstract]   [Full Text] [Related]  

  • 12. Contact dermatitis to vitamin K1 in an eye cream.
    Lopez-Lerma I; Vilaplana J
    Ann Allergy Asthma Immunol; 2013 Sep; 111(3):227-8. PubMed ID: 23987205
    [No Abstract]   [Full Text] [Related]  

  • 13. First case of contact dermatitis caused by hydroxypropyl tetrahydropyrantriol used in an anti-ageing cream.
    Assier H; Wolkenstein P; Chosidow O
    Contact Dermatitis; 2017 Jul; 77(1):60-61. PubMed ID: 28612444
    [No Abstract]   [Full Text] [Related]  

  • 14. Allergic contact dermatitis caused by hydroxyacetophenone in a face cream.
    Sanz-Sánchez T; Valverde Garrido R; Maldonado Cid P; Díaz-Díaz RM
    Contact Dermatitis; 2018 Feb; 78(2):174-175. PubMed ID: 29341188
    [No Abstract]   [Full Text] [Related]  

  • 15. Allergic contact dermatitis caused by 4-n-butylresorcinol present in a night cream for skin hyperpigmentation.
    Lapeere H; De Keyser E
    Contact Dermatitis; 2020 Aug; 83(2):134-135. PubMed ID: 32243593
    [No Abstract]   [Full Text] [Related]  

  • 16. Photoaggravated contact dermatitis caused by methylisothiazolinone.
    Trokoudes D; Banerjee P; Fityan A; Sarkany R; White IR; White JM; McFadden JP
    Contact Dermatitis; 2017 May; 76(5):303-304. PubMed ID: 28386977
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer.
    Khelwatty S; Essapen S; Bagwan I; Green M; Seddon A; Modjtahedi H
    Oncotarget; 2017 Jan; 8(5):7666-7677. PubMed ID: 28032593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a High-Throughput Genotyping Platform (OncoMap) for
    Kim D; Hong YS; Kim JE; Kim KP; Lee JL; Chun SM; Kim J; Jang SJ; Kim TW
    Cancer Res Treat; 2017 Jan; 49(1):37-43. PubMed ID: 27121720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory hypokalemia caused by cetuximab with advanced colorectal cancer patients: the case series and literature review.
    Chen YW; Yang M; Wang MX; Jiang JH; Jiang DY; Chen ZL; Yang L
    Anticancer Drugs; 2022 Jan; 33(1):e789-e794. PubMed ID: 34419963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of bevacizumab and cetuximab in metastatic colorectal cancer across selected public hospitals in Queensland.
    Chapman SJ; McKavanagh D; Burge ME; McPherson I; Walpole E; Hollingworth SA
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e253-e261. PubMed ID: 27435535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.